VP
Vlado Perkovic
UNSW Sydney
Research areas: Medicine · Nephrology · Chronic Kidney Disease and Diabetes · Diabetes Treatment and Management · Acute Kidney Injury Research
0000-0002-4257-7620
Employment
Education
Education history is unavailable.
Projects & Funding
-
Discovery and translation of evidence for new strategies to combat cardiovascular diseases National Health and Medical Research Council2014 - 2018
-
Improving outcomes in kidney disease National Health and Medical Research Council2014 - 2018
-
SIGNAL Trial National Health and Medical Research Council2013 - 2017
-
The BLOCADE Feasibility Study National Health and Medical Research Council2011 - 2013
-
PREDICTORS OF COMPLICATIONS IN PATIENTS WITH DIABETES National Health and Medical Research Council2010 - 2012
-
Australasian Kidney Trials (AKT) Network National Health and Medical Research Council2010 - 2015
-
Clinical trial of plasma exchange and glucocorticoids in vasculitis National Health and Medical Research Council2010 - 2014
-
Erythropoiesis Trialists Collaboration National Health and Medical Research Council2009 - 2010
-
ACTIVE Dialysis National Health and Medical Research Council2009 - 2012
-
Blood pressure lowering in chronic kidney disease, are current guidelines supported by the evidence? National Health and Medical Research Council2008 - 2010
-
Mechanisms of vascular disease in uraemia National Health and Medical Research Council2002 - 2002
Publications (142)
- Sex disparities in receiving evidence-based medications in patients with CKD Save
- Statistical Analysis Plan for the Aspiring to Reduce Events in Dialysis Trial (ASPIRED) Save
- Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis Save
- Kidney Disease as a Cardiovascular Disease Priority Save
- Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials Save
- Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia Save
- Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial Save
- Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program Save
- The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes Save
- Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial Save
- Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study Save
- Blood pressure lowering in type 2 diabetes : A systematic review and meta-analysis Save
- Clinical characteristics of IgA nephropathy associated with low complement 4 levels Save
- Co-payments for health care: What is their real cost? Save
- Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study Save
- The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: Population based observational study Save
- The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy Save
- The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study Save
- Worldwide access to treatment for end-stage kidney disease: A systematic review Save
- A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial Save